Section Arrow
CARL.NASDAQ
- Carlsmed Inc
Quotes are at least 15-min delayed:2026/01/07 17:21 EST
After Hours
Last
 12.8
0 (0.00%)
Bid
11.95
Ask
14.25
High 12.8 
Low 12.8 
Volume 201 
Regular Hours (Closed)
Last
 12.8
+0.365 (+2.94%)
Day High 
12.955 
Prev. Close
12.435 
1-M High
14.14 
Volume 
53.31K 
Bid
11.95
Ask
14.25
Day Low
12.385 
Open
12.415 
1-M Low
11.45 
Market Cap 
330.68M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 12.9 
20-SMA 12.83 
50-SMA 13.13 
52-W High 17.19 
52-W Low 11.45 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.99/--
Enterprise Value
347.41M
Balance Sheet
Book Value Per Share
4.01
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
13.78M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TDOCTeladoc Health7.57-0.43-5.38%-- 
After Hours 7.57 0 0.00%
TEMTempus AI Inc.69.77+0.23+0.33%36.4PE
After Hours 69.77 0 0.00%
TXG10x Genomics19.99+0.68+3.52%-- 
After Hours 19.96 -0.03 -0.15%
EVHEvolent Health4.15+0.13+3.23%-- 
After Hours 4.21 +0.06 +1.45%
GEHCGE HealthCare Technologies85.76-0.97-1.12%17.91PE
After Hours 85.6 -0.16 -0.19%
Industry overview quotes are at least 15 minutes delayed
Business Description
Carlsmed Inc is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. It is focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of AI-enabled software solutions, and interbody implants that it custom design for each patient's unique pathology and vertebral bone topography, and single-use surgical instruments. The Company designs, manufactures, and markets aprevo, a comprehensive technology platform for spine fusion surgery procedures.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.